PATENTS

[Basic patents]

1.Japan: JP5682881 (2015.1.23) Method for evaluating specific incorporation of D-glucose into cells.
2.U.S.A.: US8986656B2 (2015.3.24) Method for evaluating specific incorporation of D-glucose into cells.
3.U.S.A.: US9958450B2 (2018.5.1) L-glucose derivatives having fluorescent chromophore.
4.Europe: EP2325327B1(2013.4.24) Method for evaluating specific incorporation of D-glucose into cells.
5.Germany: DE602009015311.0(2013.4.24) Method for evaluating specific incorporation of D-glucose into cells.
6.Switzerland: CH2325327(2013.4.24) Method for evaluating specific incorporation of D-glucose into cells.
7.France: FR2325327(2013.4.24) Method for evaluating specific incorporation of D-glucose into cells.
8.U.K.: GB2325327(2013.4.24) Method for evaluating specific incorporation of D-glucose into cells.

[In Vitro Diagnosis of Cancer]

9.Japan: JP6019500 (2016.10.14) Method for detecting cancer cell using fluorescently labeled L-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled L-glucose derivative.
10.China: ZL201280015126.5 (2016.8.17) Method for detecting cancer cell using fluorescently labeled L-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled L-glucose derivative.
11.Europe: EP2703495B1 (2018.5.9) Method for detecting cancer cell using fluorescently labeled L-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled L-glucose derivative.
12.Germany: DE602012046194.2(2018.5.9) Method for detecting cancer cell using fluorescently labeled L-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled L-glucose derivative.
13.France: FR2703495(2018.5.9) Method for detecting cancer cell using fluorescently labeled L-glucose derivative, and cancer cell-imaging agent comprising fluorescently labeled L-glucose derivative.

[Coumarin]

14.Japan: JP6327565 (2018.4.27) Method for imaging cell using fluorescence-labeled sugar derivative having coumarin derivative bound thereto, and imaging agent.
15.China: ZL201380050786.1 (2016.8.24) Method for imaging cell using fluorescence-labeled sugar derivative having coumarin derivative bound thereto, and imaging agent.
16.U.S.A.: US10288604B2 (2019.5.14) Method for imaging cell using fluorescence-labeled sugar derivative having coumarin derivative bound thereto, and imaging agent.
17.Europe: EP2905620B1 (2017.12.13) Method for imaging cell using fluorescence-labeled sugar derivative having coumarin derivative bound thereto, and imaging agent.
18.France: FR2905620(2017.12.13) Method for imaging cell using fluorescence-labeled sugar derivative having coumarin derivative bound thereto, and imaging agent.
19.Germany: DE602013030901.9(2017.12.13) Method for imaging cell using fluorescence-labeled sugar derivative having coumarin derivative bound thereto, and imaging agent.

[Stomach cancer]

20.Japan: JP6406715 (2018.9.28) Methods of detecting cancer using tissue fragments derived from living organisms and methods of maintaining cells in tissue fragments derived from living organisms in vitro.

[CDG]

21.Japan: JP6566348 (2019.8.9) Glucose derivative, and cell imaging method and imaging agent using said derivative.
22.Europe: EP3130596B1(2021.1.20) Glucose derivative, and cell imaging method and imaging agent using said derivative.
23.U.K.: GB3130596(2021.1.20) Glucose derivative, and cell imaging method and imaging agent using said derivative.
24.France: FR3130596(2021.1.20) Glucose derivative, and cell imaging method and imaging agent using said derivative.
25.Germany: DE602015064978.8(2021.1.20) Glucose derivative, and cell imaging method and imaging agent using said derivative.
26.Ireland: IE3130596(2021.1.20) Glucose derivative, and cell imaging method and imaging agent using said derivative.
27.Switzerland: CH3130596(2021.1.20) Glucose derivative, and cell imaging method and imaging agent using said derivative.
28.Belgium: BE3130596(2021.1.20) Glucose derivative, and cell imaging method and imaging agent using said derivative.
29.U.S.A.: US10001487B2 (2018.6.19)Glucose derivative, and cell imaging method and imaging agent using said derivative.
30.U.S.A.: US10509041B2 (2019.12.17) Glucose derivative, and cell imaging method and imaging agent using said derivative.
31.China: ZL201580030346.9 (2019.10.1) Novel glucose derivative, and cell imaging method and imaging agent using said derivative.

[Cytodiagnosis]

32.Japan: JP6670503 (2020.3.4) Cancer cell detection method using living body-derived cells.
33.U.S.A.: US10551387B2 (2020.2.4) Cancer cell detection method using living body-derived cells.
34.Europe: EP3199638B1 (2019.5.15)Cancer cell detection method using living body derived cells.
35.France: FR3199638(2019.5.15)Cancer cell detection method using living body derived cells.
36.Germany: DE602015030527.2(2019.5.15)Cancer cell detection method using living body derived cells.

[Spheroid]

37.Japan: JP6721868 (2020.6.23) Method of making spheroids and culture medium used in the method.

[Crovit]

38.Japan: JP6888779 (2021.5. 24) Multi-surface image acquisition system, observation device, observation method, screening method, and stereoscopic reconstruction method of subject.
39.Europe: EP3435136 (2021.3.19 Intends to grant from EPO) Multi-surface image acquisition system, observation device, observation method, screening method, and stereoscopic reconstruction method of subject.
40. U.K.: GB3435136 (2021.3.19 Intends to grant from EPO) Multi-surface image acquisition system, observation device, observation method, screening method, and stereoscopic reconstruction method of subject.
41. France: FR 3435136 (2021.3.19 Intends to grant from EPO) Multi-surface image acquisition system, observation device, observation method, screening method, and stereoscopic reconstruction method of subject.
42. Germany: DE 3435136 (2021.3.19 Intends to grant from EPO) Multi-surface image acquisition system, observation device, observation method, screening method, and stereoscopic reconstruction method of subject.
43.U.S.A.: US10921256B2 (2021.2.16) Multi-surface image acquisition system, observation device, observation method, screening method, and stereoscopic reconstruction method of subject.

[ALG]

44.Japan: JP6982358 (2020.4.01) Metal carbohydrate complexes.